Cargando…
Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy
Psoriasis is a genetic chronic disease mediated by the immune system with systemic and cutaneous manifestations that can significantly deteriorate patients’ quality of life. Two–three percent of the population worldwide suffer from psoriasis and it imposes a substantial economic burden on patients....
Autores principales: | Zhu, Baohua, Jing, Mingyi, Yu, Qianying, Ge, Xiaopei, Yuan, Fan, Shi, Lanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326914/ https://www.ncbi.nlm.nih.gov/pubmed/35950130 http://dx.doi.org/10.5114/ada.2021.108445 |
Ejemplares similares
-
A Systematic Review with Meta-Analysis of Comparative Efficacy and Safety of Risankizumab and Ustekinumab for Psoriasis Treatment
por: Yu, Qianying, et al.
Publicado: (2022) -
Phytocannabinoids in the Pharmacotherapy of Psoriasis
por: Wroński, Adam, et al.
Publicado: (2023) -
Topical 0.05% clobetasol cream in the treatment of chronic hand eczema: A protocol for systematic review and meta-analysis
por: Jing, Mingyi, et al.
Publicado: (2021) -
Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis
por: Li, Ning, et al.
Publicado: (2022) -
An Update on Photodynamic Therapy of Psoriasis—Current Strategies and Nanotechnology as a Future Perspective
por: Makuch, Sebastian, et al.
Publicado: (2022)